Sign Out
1 tablet contains 0.25 or 1.0 mg (S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole dihydrochloride monohydrate equivalent to 0.18, or 0.7 mg pramipexole base, respectively.
1 extended-release tablet contains 0.375, 1.5 or 3 mg (S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole dihydrochloride monohydrate equivalent to 0.26, 1.05 or 2.1 mg pramipexole base, respectively.
Sifrol: Tablets can be divided into halves.
Excipients/Inactive Ingredients: Sifrol: mannitol, maize starch, anhydrous colloidal silica, polyvidone, magnesium stearate.
Sifrol ER: hypromellose 2208, maize starch, carbomer 941, colloidal anhydrous silica, magnesium stearate.
